Biblio

Export 2536 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is S  [Clear All Filters]
2022
S. - Y. Huang, Yang, Y. - X., Zhang, Y. - R., Kuo, K., Li, H. - Q., Shen, X. - N., Chen, S. - D., Chen, K. - L., Dong, Q., Tan, L., and Yu, J. - T., “Investigating Causal Relations Between Circulating Metabolites and Alzheimer's Disease: A Mendelian Randomization Study.”, J Alzheimers Dis, vol. 87, no. 1, pp. 463-477, 2022.
Ede Paula F. Resende, Ketelle, R., Karydas, A., Allen, I., Grinberg, L. T., Spina, S., Seeley, W. W., Perry, D. C., Miller, B., and Naasan, G., “Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1073-1080, 2022.
Ede Paula F. Resende, Ketelle, R., Karydas, A., Allen, I., Grinberg, L. T., Spina, S., Seeley, W. W., Perry, D. C., Miller, B., and Naasan, G., “Late-Onset Alcohol Abuse as a Presenting Symptom of Neurodegenerative Diseases.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1073-1080, 2022.
K. K. Bawa, Ba, J., Kiss, A., Wang, R. D., Feng, V., Swardfager, W., Andreazza, A., Gallagher, D., Marotta, G., Herrmann, N., and Lanctôt, K. L., “Lipid Peroxidation as a Marker of Apathy and Executive Dysfunction in Patients at Risk for Vascular Cognitive Impairment.”, J Alzheimers Dis, vol. 89, no. 2, pp. 733-743, 2022.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
T. Kawarabayashi, Nakamura, T., Sato, K., Seino, Y., Ichii, S., Nakahata, N., Takatama, M., Westaway, D., St George-Hyslop, P., and Shoji, M., “Lipid Rafts Act as a Common Platform for Amyloid-β Oligomer-Induced Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1189-1203, 2022.
M. Overton, Sjögren, B., Elmståhl, S., and Rosso, A., “Mild Cognitive Impairment, Reversion Rates, and Associated Factors: Comparison of Two Diagnostic Approaches.”, J Alzheimers Dis, vol. 91, no. 2, pp. 585-601, 2022.
C. LoBue, Kelley, B. J., Hart, J., Helphrey, J., Schaffert, J., C Cullum, M., Peters, M. E., and Douglas, P. M., “Mild Traumatic Brain Injury is Related to Elevated Cerebrospinal Fluid Tau in Alzheimer's Disease Dementia.”, J Alzheimers Dis, vol. 87, no. 4, pp. 1491-1496, 2022.
A. Watts, Chalise, P., Hu, J., Hui, D., Pa, J., Andrews, S. J., Michaelis, E. K., and Swerdlow, R. H., “A Mitochondrial DNA Haplogroup Defines Patterns of Five-Year Cognitive Change.”, J Alzheimers Dis, vol. 89, no. 3, pp. 913-922, 2022.
A. A. Sandberg, Manning, E., Wilkins, H. M., Mazzarino, R., Minckley, T., Swerdlow, R. H., Patterson, D., Qin, Y., and Linseman, D. A., “Mitochondrial Targeting of Amyloid-β Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-β.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1727-1744, 2022.
A. A. Sandberg, Manning, E., Wilkins, H. M., Mazzarino, R., Minckley, T., Swerdlow, R. H., Patterson, D., Qin, Y., and Linseman, D. A., “Mitochondrial Targeting of Amyloid-β Protein Precursor Intracellular Domain Induces Hippocampal Cell Death via a Mechanism Distinct from Amyloid-β.”, J Alzheimers Dis, vol. 86, no. 4, pp. 1727-1744, 2022.
G. Weinstein, O'Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
G. Weinstein, O'Donnell, A., Davis-Plourde, K., Zelber-Sagi, S., Ghosh, S., DeCarli, C. S., Thibault, E. G., Sperling, R. A., Johnson, K. A., Beiser, A. S., and Seshadri, S., “Non-Alcoholic Fatty Liver Disease, Liver Fibrosis, and Regional Amyloid-β and Tau Pathology in Middle-Aged Adults: The Framingham Study.”, J Alzheimers Dis, vol. 86, no. 3, pp. 1371-1383, 2022.
P. Aguilar-Calvo, Sevillano, A. M., Rasool, S., Cao, K. J., Randolph, L. M., Rissman, R. A., Sarraf, S. T., Yang, J., and Sigurdson, C. J., “Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1137-1145, 2022.
P. Aguilar-Calvo, Sevillano, A. M., Rasool, S., Cao, K. J., Randolph, L. M., Rissman, R. A., Sarraf, S. T., Yang, J., and Sigurdson, C. J., “Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1137-1145, 2022.
P. Aguilar-Calvo, Sevillano, A. M., Rasool, S., Cao, K. J., Randolph, L. M., Rissman, R. A., Sarraf, S. T., Yang, J., and Sigurdson, C. J., “Noninvasive Antemortem Detection of Retinal Prions by a Fluorescent Tracer.”, J Alzheimers Dis, vol. 88, no. 3, pp. 1137-1145, 2022.
S. Cardoso, Silva, D., Alves, L., Guerreiro, M., and de Mendonça, A., “The Outcome of Patients with Amyloid-Negative Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 86, no. 2, pp. 629-640, 2022.
P. Agarwal, Holland, T. M., James, B. D., Cherian, L. J., Aggarwal, N. T., Leurgans, S. E., Bennett, D. A., and Schneider, J. A., “Pelargonidin and Berry Intake Association with Alzheimer's Disease Neuropathology: A Community-Based Study.”, J Alzheimers Dis, vol. 88, no. 2, pp. 653-661, 2022.
X. Shi, Zhou, N., Sun, B., Wu, Y., Hu, Y., and Ning, Y., “Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1329-1337, 2022.
X. Shi, Zhou, N., Sun, B., Wu, Y., Hu, Y., and Ning, Y., “Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology.”, J Alzheimers Dis, vol. 90, no. 3, pp. 1329-1337, 2022.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
B. Rippon, Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., and Luchsinger, J. A., “Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1229-1238, 2022.
J. R. Wright, Deen, Q. Fahm E., Stevenson, A., Telford-Cooke, L., Parker, C., Martin-Ruiz, C., Steinert, J. R., Kalaria, R. N., and Mukaetova-Ladinska, E. B., “Plasma Myeloperoxidase as a Potential Biomarker of Patient Response to Anti-Dementia Treatment in Alzheimer's Disease.”, J Alzheimers Dis, vol. 89, no. 4, pp. 1483-1492, 2022.

Pages